01
Growth leader
Poland → Hungary
+21,345.9%3-year CAGR
$421.1M latest value · 15.4% share
Route intelligence
The routes that move Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
A sharper view of the exporter-to-importer lanes behind the product. Start with the routes that matter most, then compare growth, access, and emerging signals.
Leading corridorIreland → USA, Puerto Rico and US Virgin Islands$13.5B latest reported trade
Top five concentration97.8%share of the displayed product total
Latest reported year2024100 tracked route records
Market pulseReported movementproduct-level direction
Growth lanes86corridors with positive 3-year growth
Access coverage64routes with reported FTA context
View statusReportedderived route comparison
The corridor workbench
Where the product actually moves
Ranked by the latest reported trade value. Use growth and access together; a large lane is not automatically an easy lane.
Top 100 corridorsLatest reported value
| Rank | Route | Trade value | 3-year growth | Share | Access | Signal |
|---|---|---|---|---|---|---|
| 01 | Ireland → USA, Puerto Rico and US Virgin IslandsIRL / USA | $13.5B | +0.5% | 20% | No FTA reported | Accelerating |
| 02 | Switzerland, Liechtenstein → USA, Puerto Rico and US Virgin IslandsCHE / USA | $13.0B | +12.6% | 19.2% | No FTA reported | Accelerating |
| 03 | Germany → USA, Puerto Rico and US Virgin IslandsDEU / USA | $10.4B | +15.5% | 15.3% | No FTA reported | Accelerating |
| 04 | Singapore → USA, Puerto Rico and US Virgin IslandsSGP / USA | $8.5B | +81.3% | 12.6% | FTA reported | Accelerating |
| 05 | Ireland → NetherlandsIRL / NLD | $4.2B | +77.4% | 30.7% | FTA reported | Accelerating |
| 06 | Switzerland, Liechtenstein → GermanyCHE / DEU | $3.8B | +0.5% | 25.9% | FTA reported | Growing |
| 07 | Belgium → USA, Puerto Rico and US Virgin IslandsBEL / USA | $3.7B | +23.7% | 5.5% | No FTA reported | Accelerating |
| 08 | Netherlands → USA, Puerto Rico and US Virgin IslandsNLD / USA | $3.7B | +29.3% | 5.5% | No FTA reported | Growing |
| 09 | Japan → USA, Puerto Rico and US Virgin IslandsJPN / USA | $3.4B | +14.4% | 5% | No FTA reported | Accelerating |
| 10 | Switzerland, Liechtenstein → BelgiumCHE / BEL | $3.3B | +13.7% | 64.7% | FTA reported | Accelerating |
| 11 | Italy → NetherlandsITA / NLD | $2.8B | +26.3% | 20.3% | FTA reported | Accelerating |
| 12 | United Kingdom → USA, Puerto Rico and US Virgin IslandsGBR / USA | $2.7B | +23.7% | 4% | No FTA reported | Accelerating |
| 13 | USA, Puerto Rico and US Virgin Islands → JapanUSA / JPN | $2.7B | +9.9% | 31.1% | No FTA reported | Accelerating |
| 14 | Italy → USA, Puerto Rico and US Virgin IslandsITA / USA | $2.7B | +32.4% | 3.9% | No FTA reported | Accelerating |
| 15 | Switzerland, Liechtenstein → ChinaCHE / CHN | $2.6B | +18.1% | 25.6% | FTA reported | Accelerating |
| 16 | Austria → USA, Puerto Rico and US Virgin IslandsAUT / USA | $2.6B | +52.7% | 3.8% | No FTA reported | Accelerating |
| 17 | Germany → NetherlandsDEU / NLD | $2.6B | -2.9% | 18.8% | FTA reported | Slowing |
| 18 | USA, Puerto Rico and US Virgin Islands → ChinaUSA / CHN | $2.3B | -1.4% | 22.8% | No FTA reported | Accelerating |
| 19 | USA, Puerto Rico and US Virgin Islands → GermanyUSA / DEU | $2.2B | +1.3% | 15.1% | No FTA reported | Growing |
| 20 | Germany → Switzerland, LiechtensteinDEU / CHE | $2.2B | +4.2% | 27.1% | FTA reported | Accelerating |
| 21 | USA, Puerto Rico and US Virgin Islands → NetherlandsUSA / NLD | $2.1B | +3.5% | 15.5% | No FTA reported | Growing |
| 22 | Germany → ChinaDEU / CHN | $1.9B | -4.5% | 18.3% | No FTA reported | Accelerating |
| 23 | Switzerland, Liechtenstein → FranceCHE / FRA | $1.7B | +14% | 25.7% | FTA reported | Growing |
| 24 | Germany → ItalyDEU / ITA | $1.7B | -7.1% | 27.1% | FTA reported | Growing |
| 25 | Ireland → ChinaIRL / CHN | $1.7B | +23.4% | 16.9% | No FTA reported | Accelerating |
Movement to watch
Growth leaders and emerging lanes
The strongest growth rates are a starting point for investigation, not a forecast. Check the underlying value and route conditions.
02
Growth leader
Denmark → Switzerland, Liechtenstein
+690.8%3-year CAGR
$496.6M latest value · 6.2% share
03
Growth leader
Denmark → Netherlands
+612.9%3-year CAGR
$672.3M latest value · 4.9% share
04
Growth leader
United Kingdom → France
+242.8%3-year CAGR
$502.1M latest value · 7.4% share
Emerging signals
Routes changing shape
These corridors carry a reported signal or a non-routine attention label in the available route context.
AcceleratingIreland → USA, Puerto Rico and US Virgin Islands+0.5%
AcceleratingSwitzerland, Liechtenstein → USA, Puerto Rico and US Virgin Islands+12.6%
AcceleratingGermany → USA, Puerto Rico and US Virgin Islands+15.5%
AcceleratingSingapore → USA, Puerto Rico and US Virgin Islands+81.3%
Access comparison
Does preferential access show up in the route mix?
Compare the value and growth of corridors with a reported free-trade agreement indicator against corridors without one. This is context for research, not a tariff recommendation.
Read the methodology ↗FTA reported$76.6B
64 corridors · +376.1% average growthNo FTA reported$80.7B
36 corridors · +35.7% average growthAccess fields are shown only where reported context is available.
How to read this view
Scale, momentum, and access belong in the same frame.
Trade value identifies the routes with the largest observed footprint. Growth shows how that footprint has changed over the available three-year comparison. Share indicates the route's position within the displayed product view.
Distance, FTA status, volatility, and signals add context from supporting bilateral datasets. Missing values are not filled or treated as zero.
Data source
OECD trade statistics with CEPII context
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-27). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.